 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
 |
 |
 |
 |
|
Articles
|
|
|
 |
A cross section of industry players peer into the crystal ball to offer their predictions of what drug sampling may look like in the not-too-distant future. Appeared in August 2009 MedAdNews. Used with Permission. |
|
|
|
 |
Boost Retention Rates with Serious Game-based Learning Learn more about the application of serious games in biopharma in this Total Learning Concepts/Publicis Selling Solutions article that appeared in the spring 2009 issue of SPBT FOCUS. Appeared in Spring 2009 SPBT FOCUS. Used with Permission. |
|
|
|
 |
Four Trends Drive the Future of Sampling Rick Keefer, President & CEO of Publicis Strategic Solutions Group, details four trends that will shape the way drugs are sampled in the coming years in this interview with MedAdNews. Appeared in August 2009 MedAdNews. Used with Permission. |
|
|
|
 |
PharmaVOICE 100 Most Inspiring People Publishing the fifth annual special issue featuring 100 of the most inspiring individuals in the life-sciences industry, PharmaVoice features Rick Keefer, President of Publicis Selling Solutions Group. Appeared in July/August 2009 PharmaVoice. Used with Permission. |
|
|
|
 |
Readers were asked to prognosticate on the future and identify the top trends they expect to shape the industry in the coming year and beyond. Rick Keefer, President of Publicis Healthcare Communications Messaging Group speaks out on pages 23-24 of the magazine (pg 22-23 of the PDF)... Appeared in November/December 2008 PharmaVoice. Used with Permission. |
|
|
|
 |
The New Blended Sales Model: Are Clinical Health Educators in the Mix? As the industry becomes increasingly more complex, biopharmaceutical companies are recognizing the need to deliver messages to a widening range of customers, including managed markets, patients, pharmacists, and of course, physicians. Read more in this guest commentator article by Rick Keefer, COO Publicis Selling Solutions Group... Appeared in September 2008 PM360. Used with Permission. |
|
|
|
 |
As the industry turns its attention toward specialty products in the hopes of filling drying pipelines, smaller pharma and biotech companies may find themselves in the drivers seat.. Appeared in September 2008 PharmaVoice. Used with Permission. |
|
|
|
 |
Redefining the Salesforce Landscape to Navigate New Territories Over the past decade, the industry has invested in new tools and technologies to meet the rising pressures of meeting sales goals caused by drying pipelines, patent expirations, managed care, and dwindling sales forces. The real need, however, is for a dramatic shift in thinking around processes... Appeared in June 2008 PharmaVoice. Used with Permission. |
|
|
|
 |
Cutting-edge, fast-paced, highly competitive computer-based simulations and games designed to educate as they engage are gaining traction in the industry... Appeared in January 2008 PharmaVoice. Used with Permission. |
|
|
|
 |
In the future, the salesforce army of today will be but a distant memory as a new sales model emerges that uses sophisticated selling techniques, technologies, and education to support rep's interaction with physicians and other healthcare providers in the continuum... Appeared in Nov/Dec 2007 PharmaVoice. Used with Permission. |
|
|
|
 |
Is the Decile Model Becoming Outmoded? For years pharmaceutical sales teams have targeted physicians based solely on their prescribing volume. Technology advances, process enhancements, and new messaging formats are offering new and improved ways of accessing physicians... Appeared in Oct 2007 PharmaVoice. Used with permission. |
|
|
|
 |
The Face of the New BioPharma Rep With today's sales force in flux, pharma is looking to a new sales elite. Take a look inside "tomorrow's" sales force... Appeared in Pharmaceutical Executive magazine. Used with permission. |
|
|
|
 |
Until Recently, Building Up Pharma's Arms Race of Reps Since reps were the primary influencers of physicians’ prescribing behaviors, increasing the number of feet on the street proved that companies were hard at work, with reps reaching the high prescribers with as much frequency as possible. The “mirrored” or “pod” sales force—criticized today by many—was an insurance policy of sorts back then, intended to gain greater message penetration than the competition. This approach was considered safe... Appeared in Pharmaceutical Executive magazine. Used with permission. |
For more information about sales force options for your brand today, contact:
Daniella Shtemberg, Business Development, at
dominate@pSellingSolutions.com or call toll-free (866) 616-4777
© Publicis Selling Solutions. All Rights Reserved. Privacy Policy. Website Terms & Conditions.
2000 Lenox Drive, Suite 100, Lawrenceville, NJ 08837 USA 
Sign Up for News.